Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer

UNC Lineberger Comprehensive Cancer Center

Status: Terminated

Conditions: Prostate Cancer

Treatments: Behavioral: Walk with Ease

Study type: Observational

Funder types: Other

Identifiers

NCT02139774

13-2929 (Other Identifier)

LCCC1320

Details and patient eligibility

About

This study is testing a walking program called Walk with Ease by the Arthritis Foundation with men undergoing treatment for prostate cancer. The researchers are interested in how easy or difficult it is for these men to participate in this program and whether or not is is helpful to them during their care.

Full description

Purpose: This pilot study evaluates the feasibility of implementing a moderate-intensity physical activity (PA) program in a sample of men age 65 or older with a prostate cancer diagnosis undergoing various forms of treatment or active surveillance.

Participants: Men, 65 and older, with a prostate cancer diagnosis.

Procedures (methods): This study will enroll subjects in a 6 week walking program called Walk with Ease (WWE) and see if walking can be sustained for up to three months. In addition, the study will perform a Geriatric Assessment and gather preliminary data on self-reported quality of life outcomes and self-reported physical activity as captured in a daily walking log.

Enrollment: 15 patients

Sex: Male

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ≥65 years of age
• Histologically confirmed Stage I, II or III prostate cancer (endocrine (± radiation) patients may be Stage IV)
• Undergoing prostate cancer treatment (post-surgery only, radiation only, endocrine therapy (± radiation), or active surveillance)
• English speaking
• IRB approved, signed written informed consent
• Approval from their treating physician to engage in moderate-intensity physical activity
• Patient-assessed ability to walk and engage in moderate physical activity
• Willing and able to meet all study requirements

Exclusion criteria

• One or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention
• Major surgery scheduled within the study period
• Unable to walk or engage in moderate-intensity physical activity
• Already actively walking (150 minutes per week)

Trial design

15 participants in 4 patient groups

Active Survelliance

Description:

Men age 65 and older who are undergoing active surveillance as primary treatment for their prostate cancer.

Treatment:

Behavioral: Walk with Ease

Radiation

Description:

Men age 65 and older who are undergoing radiation only as primary treatment for their prostate cancer.

Treatment:

Behavioral: Walk with Ease

Endocrine Therapy

Description:

Men age 65 and older who are undergoing endocrine therapy as primary treatment for their prostate cancer.

Treatment:

Behavioral: Walk with Ease

Surgery

Description:

Men age 65 and older who are undergoing surgery as primary treatment for their prostate cancer.

Treatment:

Behavioral: Walk with Ease